Paul Geoffrey Skett

Title: The Innovative Contributions of Paul Geoffrey Skett

Introduction

Paul Geoffrey Skett is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of herbal medicine, particularly through his innovative patent related to the Artemisia family of herbs. His work focuses on enhancing the therapeutic properties of these herbs while minimizing potential risks.

Latest Patents

Skett holds a patent for the "Artemisia judaica fractionation method." This method involves the chromatographic fractionation of extracts from herbs in the Artemisia family, which are traditionally known for their anti-diabetic effects. The process aims to remove undesirable mutagenetic properties while preserving the herbs' effectiveness against Diabetes mellitus. Notably, certain fractions exhibit insulinomimetic properties, while others act as glucagon antagonists. The optimal clinical effect is achieved through the combination of these fractions.

Career Highlights

Throughout his career, Paul Geoffrey Skett has been dedicated to advancing the understanding and application of herbal extracts in medicine. His innovative approach to fractionation has opened new avenues for research and treatment in diabetes management. He is currently associated with Phyto Tech Corp., where he continues to explore the potential of herbal remedies.

Collaborations

Skett collaborates with Brian Anthony Whittle, contributing to the development of effective herbal solutions. Their partnership exemplifies the importance of teamwork in the field of innovation and research.

Conclusion

Paul Geoffrey Skett's work in the fractionation of Artemisia extracts represents a significant advancement in herbal medicine. His innovative methods not only enhance the therapeutic potential of these herbs but also ensure their safety for clinical use.